Connect with us


CBD oil legality in the EU: A changing landscape



You’ve probably heard the hype already about the trendy benefits of CBD Oil. It is a natural substance derived from the hemp plant popping up in all kinds of forms in Europe’s food and beauty industry thanks to its medicinal properties.

Today, Europe has the 2nd largest CBD market in the world –only behind North America. From CBD gummies and potato chips to CBD facial masks, every entrepreneur wants in on this booming industry.

As of writing, CBD is legal in most European countries, explaining the meteoric rise in CBD use in the continent. However, it hasn’t been all plain sailing for this budding market –the pun intended.

Enter the EU’s restrictive CBD oil regulations. While the European CBD market is expanding exponentially, the ever-changing rules on CBD legality have proved a major handicap.

Let’s look at what CBD oil is, its legality in Europe, and what the future holds for CBD legality in Europe

What is CBD oil?

Not to be confused with hemp oil, CBD oil is the most popular form of Cannabidiol (CBD) –an active naturally occurring cannabinoid found in cannabis plants. CBD is mainly extracted from the hemp tree and then dissolved into plant-based oils such as olive oil or castor oil to form CBD oil.

Most people use the terms CBD oil and hemp oil interchangeably since both are hemp extracts. However, these two oils couldn’t be more different. For instance, while CBD oil is extracted from the leaves, stem and flowers of the hemp, hemp oil is explicitly obtained from the hemp seeds. What’s more, hemp seeds don’t contain any CBD; hence, hemp oil doesn’t have CBD oil's health benefits.

What about THC, the ingredient that made the cannabis plant famous, you ask. Well, Tetrahydrocannabinol (THC) is another active cannabinoid mainly found in the marijuana plant –a cousin of the hemp plant. THC is known for its psychoactive effects, which give you the “high.”

The World Health Organisation (WHO) reports that CBD oil doesn’t have any of these psychoactive effects, unlike THC. Besides, since the hemp plant only contains very low THC levels (less than 0.2%), most European countries’ CBD regulations stipulate that products use hemp-extracted CBD only. More on this later.

Is CBD oil legal in the EU?

While it has been legal to cultivate and supply hemp plants for hemp fibre (with less than 0.2% THC) in the EU for some time now, CBD oil legality around Europe is quite complex.

That said, Europe stands out as one of the most liberal regions in terms of cannabis legalisation. Today, CBD oil is legal in almost all countries in Europe. However, there is still a lack of consensus on CBD products' legality –the only consensus seems to be on the use of CBD extracted from the hemp plant.

For instance, in the UK, farmers are allowed to grow hemp as long as you have a licence from the UK Home Office. However, you can only use this hemp for its fibre and seed oil. And as we noted earlier, the seeds do not contain any CBD.

Therefore, while the use of CBD products — derived from hemp containing less than 0.2% THC — and growing hemp is perfectly legal in the UK, you cannot harvest and process hemp flowers and leaves for CBD oil, among other products.

In other countries such as Belgium, Greece and Switzerland, the regulations allow for the cultivation and processing of hemp flower.

Switzerland was among the first countries to allow the sale of hemp flower. Besides, their regulations allow for a higher THC limit (1%), which means they have high-quality CBD buds.

Other countries with notably high THC limits include Italy (0.6%) and Austria (0.3%).

Here is a list of countries in Europe where hemp flower and CBD products are legal:

  • Switzerland
  • Belgium
  • Luxembourg
  • Austria
  • Spain
  • Czech Republic
  • Greece
  • Poland

It’s worth noting that while the sale and use of CBD flowers is illegal in countries such as Italy, France, Germany, the UK, Netherlands, Sweden and other Scandinavian countries, CBD products are entirely legal – subject to local laws.

CBD is completely illegal in Andorra, Albania, Armenia, Belarus, Lithuania and Slovakia.

CBD regulation as a novel food

In January 2019, the EU, through the European Food Safety Authority (EFSA), directed all cannabinoid-infused food products to be approved as novel foods. Well, although this new regulation is not mandatory, most countries are applying it and tightening their laws around the CBD market.

A substance is considered a novel food if it was not consumed significantly before 1997. This means companies manufacturing CBD products such as oils, cookies and drinks must have a novel food license before selling them within the EU.

The idea behind this regulation is to make sure CBD products are:

  • Safer for human consumption, and;
  • properly labelled to prevent misleading consumers.

The call for CBD's inclusion in the EU’s Novel Food Catalogue has led to an uproar across the cannabis industry. While some people believe it will make CBD products safer, CBD manufacturers see it as an extra financial and regulatory burden.

Classification of CBD as a narcotic by EU

Before the dust had settled on EU’s regulation of CBD as a novel food, the European Commission (EC) decided to pause all Novel Food applications for CBD products. They intend to classify CBD as a narcotic since it is extracted from the hemp plant's flowers.

This is based on the UN’s Single Convention on Narcotic Drugs from 1961. The treaty states that “extracts and tinctures” of hemp’s flowering tops are classed as narcotics.

If classified as a narcotic, this will stifle current Europe’s CBD market. For instance, you’ll be unable to retail CBD products on the European market legally. Besides, this is likely to hinder cannabinoid research and innovation in Europe while also stifling opportunities for a legal and regulated CBD industry.

However, as expected, the European Industrial Hemp Association (EIHA) has come out and rejected the decision. The trade group decries this controversial policy is against both the EU’s green ambition and the growing CBD demand in Europe.

There are valid fears that enforcing this policy might create a large unregulated grey CBD market leading to low-quality products and improper labeling.

A changing landscape: What the future holds for CBD oil in Europe

Enforcing prohibitions on the current ever-growing CBD market will be costly. What’s more, with the economic contraction facing the EU countries in the post-COVID-19 era, member states are unlikely to invest heavily in CBD-focused polices.

Besides, we already have countries such as the UK deviating from the EU’s novel food rule. TheUK’s Food Safety Association (FSA)already has plans to operate its own independent novel food approval program in 2021.

Therefore, CBD manufacturers will not have to worry about EC’s decision to pause the novel food applications. The program will allow UK operators to submit applications for CBD extracted from hemp flowers opening clear pathways to legal CBD sales.

On the other hand, the European Commission is yet to issue a final decision on their recommendation as they await on the UN’s Committee on Narcotic Drugs (CND) vote regarding the amendment of the 1961 cannabis treaty. The main proposals involve deleting the extracts and tinctures of the cannabis category and clarifying the control of CBD products with less than 0.2% THC.

It is difficult to tell when this vote will happen. However, one thing is certain; the decision will be quite disruptive – not only in Europe but also throughout the world’s CBD market.

That said, Europe’s CBD demand is on an unstoppable upward growth. As we wait on the regulatory bodies’ verdict, it is always advisable to use CBD products from registered and trusted companies. Also, remember to check for third-party lab reports to confirm the product's safety and legality before purchase.


#COVID-19 - ‘This year’s Christmas will be a different Christmas’



Today (28 October) the European Commission presented its proposals for additional measures to tackle the COVID-19 ahead of tomorrow’s meeting, via videoconference, of European heads of government. 

The measures are aimed at a more coordinated approach to data sharing, testing, medical and non-medical equipment, to travel, and to vaccination strategies. President of the European Commission, von der Leyen, called for cooperation, coordination and solidarity. 

Von der Leyen said: “Today we are launching additional measures in our fight against the virus; from increasing access to fast testing and preparing vaccination campaigns, to facilitating safe travel when necessary. I call on the Member States to work closely together. Courageous steps taken now will help save lives and protect livelihoods. No Member State will emerge safely from this pandemic until everyone does.”

Commissioner for Health and Food Safety Stella Kyriakides said: “The rise in COVID-19 infection rates across Europe is very alarming. Decisive immediate action is needed for Europe to protect lives and livelihoods, to alleviate the pressure on healthcare systems, and to control the spread of the virus.”

Professor Peter Piot, who is the lead scientist in the Commission’s panel of advisors echoed the President’s concerns, saying that there was no “silver bullet”. He said that Europe was paying a high price for relaxing measures in the summer, adding that measures like wearing the mask work as long as everyone does it.

He also warned against ‘corona fatigue’ and underlined that there was no trade-off between health and the economy. Pointing to a report in the Financial Times, he said that the health issue needed to be fixed to limit economic damage. 

The new efforts, look at many actions:

Improving the flow of information to allow informed decision-making: The sharing of accurate, comprehensive, comparable and timely information on epidemiological data, as well as on testing, contact tracing and public health surveillance, is essential to track how the coronavirus spreads at regional and national level and providing all relevant data to the European Centre for Disease Prevention and Control (ECDC) and the Commission.

Establishing more effective and rapid testing: The Commission is proposing directly purchase rapid antigen tests and delivering them to Member States, using €100 million under the Emergency Support Instrument. In parallel, the Commission is launching a joint procurement to ensure a second stream of access. Travellers should be offered the possibility to undergo a test after arrival. If negative COVID-19 tests are to be required or recommended for any activity, mutual recognition of tests is essential, in particular in the context of travel.

Making full use of contact tracing and warning apps across borders:  EU member states have developed 19 national contact tracing and warning apps, downloaded more than 52 million times. The Commission recently launched a solution for linking national apps across the EU through a ‘European Federation Gateway Service'. Three national apps (Germany, Ireland, and Italy) were first linked on 19 October when the system came online. The Commission calls on all states to set up effective and compatible apps and reinforce their communication efforts to promote their uptake.

Effective vaccination: The development and uptake of safe and effective vaccines is a priority effort to quickly end the crisis. Member States need to take to be fully prepared, which includes the development of national vaccination strategies. The Commission will put in place a common reporting framework and a platform to monitor the effectiveness of national vaccine strategies. To share the best practices, the conclusions of the first review on national vaccination plans will be presented in November 2020.

Effective communication to citizens: Clear communication is essential for the public health response to be successful, the Commission is calling on all Member States to relaunch communication campaigns to counter false, misleading and dangerous information that continues to circulate, and to address the risk of “pandemic fatigue”. Vaccination is a specific area where public authorities need to step up their actions to tackle misinformation and secure public trust, as there will be no compromise on safety or effectiveness under Europe's robust vaccine authorization system. 

Securing essential supplies: The Commission has launched a new joint procurement for medical equipment for vaccination.

Facilitating safe travel: The Commission calls on member states to fully implement the Recommendation adopted by the Council for a common and coordinated approach to restrictions to free movement. Citizens and businesses want clarity and predictability. Any remaining COVID-19 related internal border control measures should be lifted.

Continue Reading


European minimum wage: Commission proposal welcome but falls short on ambition to fight poverty and inequality say Greens



The European Commission has just released its draft directive on a European minimum wage. The proposal sets out minimum standards and uniform criteria for the level of EU-wide minimum wages. The European Commission is calling on EU governments to involve social partners and trade unions in negotiations on minimum wages and to close gaps where collective agreements do not apply.

For the Greens/EFA group, the European Commission's proposal falls short of its stated ambition to fight poverty and inequality. Kira Peter-Hansen MEP, Greens/EFA co-ordinator in the Employment and Social Affairs Committee in the European Parliament, said: "Too many Europeans earn a wage they cannot live on and the number of ‘working poor’ is likely to grow during the current COVID-19 crisis. That's why it's welcome that the Commission is attempting to tackle the issue of in-work poverty, but unfortunately this proposal fails to tackle the issue.

"If a European framework on minimum wages is to make a real difference then this proposal is not up to the job. As it stands, this Directive will still see workers on as little as two euros an hour. Wages must be enough to live on across the whole of the EU.

"We welcome the proposal to guarantee wages based on collective agreements in public procurement. However, more needs to be done to give social partners the means to strengthen collective bargaining and we need to secure that the proposal do not harm well-functioning collective bargaining models European workers need access to poverty-proof wages and for the eradication of discrimination of any kind, and for all EU citizens to have a minimum income - that’s what a true Social Europe is about."

Continue Reading


Samsung Display gets US licenses to supply some panels to Huawei




Samsung Electronics’ display unit has received licenses from US authorities to continue supplying certain display panel products to Huawei Technologies [HWT.UL], a source familiar with the matter told Reuters on Tuesday (27 October).

With US-China ties at their worst in decades, Washington has been pushing governments around the world to squeeze out Huawei, arguing that the telecom giant would hand data to the Chinese government for spying. Huawei denies it spies for China.

From 15 September, new curbs have barred US companies from supplying or serving Huawei.

Samsung Display, which counts Samsung Electronics and Apple as major customers for organic light-emitting diode (OLED) display screens, declined comment.

Huawei was not immediately available for comment.

It is still unclear whether Samsung Display will be able to export its OLED panels to Huawei as other firms in the supply chain making components necessary to manufacture panels would also have to get U.S. licences.

Samsung’s cross-town rival LG Display said that it and other companies, including most semiconductor companies, need to get licences to resume business with Huawei.

Last month, Intel Corp said it had received licences from US authorities to continue supplying certain products to Huawei.

Continue Reading